Mukherjee, Kamalika http://orcid.org/0000-0002-5483-7450
Gu, Changkyu
Collins, Agnieszka http://orcid.org/0000-0001-5601-6747
Mettlen, Marcel
Samelko, Beata
Altintas, Mehmet M. http://orcid.org/0000-0002-1871-6985
Sudhini, Yashwanth R.
Wang, Xuexiang http://orcid.org/0000-0002-4091-8196
Bouley, Richard http://orcid.org/0000-0003-0443-0756
Brown, Dennis
Pedro, Bradley P.
Bane, Susan L.
Gupta, Vineet http://orcid.org/0000-0001-6987-2550
Brinkkoetter, Paul T.
Hagmann, Henning
Reiser, Jochen
Sever, Sanja http://orcid.org/0000-0001-6774-4109
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK093773, R01 DK087985, R01 DK084195)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | National Institutes of Health (GM73165, CA227747)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 5 April 2021
Accepted: 4 April 2022
First Online: 3 May 2022
Competing interests
: S.S. and J.R. are co-founders and shareholders of Walden Biosciences, a biotechnology company that develops novel kidney-protective therapies. S.L.B. and K.M. are inventors on a pending patent application pertaining to the detection of oxidative stress-induced carbonylation. The remaining authors declare no competing interests.